Cargando…
Effects of Aging on Levo-Dihydroxyphenylalanine- Induced Dyskinesia in a Rat Model of Parkinson’s Disease
BACKGROUND: It remains unclear why patients with young-onset Parkinson’s disease more often develop levo-dihydroxyphenylalanine (L-dopa)-induced dyskinesia (LID) and have a more severe form than patients with old-onset Parkinson’s disease. Previous studies using animal models have failed to show you...
Autores principales: | Nishijima, Haruo, Kimura, Tamaki, Mori, Fumiaki, Wakabayashi, Koichi, Kinoshita, Iku, Nakamura, Takashi, Kon, Tomoya, Suzuki, Chieko, Tomiyama, Masahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155371/ https://www.ncbi.nlm.nih.gov/pubmed/34054505 http://dx.doi.org/10.3389/fnagi.2021.650350 |
Ejemplares similares
-
Axon terminal hypertrophy of striatal projection neurons with levodopa-induced dyskinesia priming
por: Nakamura, Takashi, et al.
Publicado: (2023) -
Predictors of Levo-dopa induced Dyskinesias in Parkinson's Disease
por: Athulya, RT, et al.
Publicado: (2020) -
Clinical Utility of Skin Biopsy in Differentiating between Parkinson's Disease and Multiple System Atrophy
por: Haga, Rie, et al.
Publicado: (2015) -
Evaluation of cerebral blood flow in older patients with status epilepticus using arterial spin labeling
por: Ueno, Tatsuya, et al.
Publicado: (2018) -
Spine Enlargement of Pyramidal Tract-Type Neurons in the Motor Cortex of a Rat Model of Levodopa-Induced Dyskinesia
por: Ueno, Tatsuya, et al.
Publicado: (2017)